Simply Wall St.
How Conditional FDA Approval of Credelio Quattro-CA1 Could Impact Elanco Animal Health (ELAN) Investors
📊
AI Sentiment
Positive
7/10
- Home
- ELAN
as of 12-24-2025 1:00pm EST
$22.38
+$0.16
+0.72%
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
| Founded: | 1954 | Country: | United States |
| Employees: | N/A | City: | GREENFIELD |
| Market Cap: | 10.3B | IPO Year: | 2018 |
| Target Price: | $23.11 | AVG Volume (30 days): | 6.1M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.07 | EPS Growth: | -82.84 |
| 52 Week Low/High: | $8.02 - $23.70 | Next Earning Date: | 11-05-2025 |
| Revenue: | $4,591,000,000 | Revenue Growth: | 3.08% |
| Revenue Growth (this year): | 7.19% | Revenue Growth (next year): | 5.32% |
AI-Powered ELAN Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 78.57%
78.57%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Elanco Animal Health Incorporated (ELAN)
Kurzius Lawrence Erik
Buy
Director
ELAN Dec 12, 2025
Avg Cost/Share
$21.30
Shares
10,000
Total Value
$213,000.00
Owned After
131,773
SEC Form 4
Simmons Jeffrey N
Buy
PRESIDENT, CEO AND DIRECTOR
ELAN Dec 11, 2025
Avg Cost/Share
$21.75
Shares
22,000
Total Value
$478,495.60
Owned After
167,000
SEC Form 4
Modi Rajeev A.
Buy
SEE REMARKS
ELAN Dec 11, 2025
Avg Cost/Share
$21.33
Shares
4,500
Total Value
$95,985.00
Owned After
123,082
SEC Form 4
VanHimbergen Robert M
Buy
EVP and CFO
ELAN Dec 11, 2025
Avg Cost/Share
$21.64
Shares
6,950
Total Value
$150,426.50
Owned After
124,233
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | ELAN | Director | Dec 12, 2025 | Buy | $21.30 | 10,000 | $213,000.00 | 131,773 | |
| Simmons Jeffrey N | ELAN | PRESIDENT, CEO AND DIRECTOR | Dec 11, 2025 | Buy | $21.75 | 22,000 | $478,495.60 | 167,000 | |
| Modi Rajeev A. | ELAN | SEE REMARKS | Dec 11, 2025 | Buy | $21.33 | 4,500 | $95,985.00 | 123,082 | |
| VanHimbergen Robert M | ELAN | EVP and CFO | Dec 11, 2025 | Buy | $21.64 | 6,950 | $150,426.50 | 124,233 |
Latest Elanco Animal Health Incorporated News
ELAN Breaking Stock News: Dive into ELAN Ticker-Specific Updates for Smart Investing
Insider Monkey
Jim Cramer on Elanco Animal Health: “They Are Doing Everything Right”
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Does Elanco’s 85% 2025 Rally Match Its Long Term Valuation Prospects?
📈
AI Sentiment
Highly Positive
9/10
Barrons.com
Elanco CEO Bites Off More Shares of Fast-Rising Stock
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Elanco Says Credelio Quattro-CA1 Got FDA Conditional Approval for Treatment of New World Screwworm in Dogs
➖
AI Sentiment
Neutral
5/10
PR Newswire
Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs
📈
AI Sentiment
Highly Positive
9/10
Motley Fool
Black Creek Dumps 999,000 Shares of Baidu Stock Worth $49.1 Million
➖
AI Sentiment
Neutral
4/10
Compare ELAN vs Leading Stocks
See how ELAN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ELAN Elanco Animal Health Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.